Delivery Order SPE2DB20D2104-SPE2DB25FMXUZ
- Not listed
- The Defense Logistics Agency awarded a $11,046.77 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 3, 2025, with completion scheduled for September 4, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $12,804.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen (0.5 mL) on September 8, 2025, with completion expected by September 9, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single pharmaceutical procurement transaction under the company's broader...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency awarded a $2,360.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,843.65 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 16, 2025, with completion scheduled for September 17, 2025. This delivery order represents a firm fixed price procurement issued under a non-set-aside competitive acquisition. The award was placed to AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $1,632.54 delivery order contract to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of June 4, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's medical...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This contract was awarded competitively with no set-aside designation and has an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger procurement vehicle...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXUZDelivery Order
The Defense Logistics Agency awarded a $1,632.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen (0.5 mL) on August 14, 2025, with completion targeted for August 15, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger pharmaceutical supply framework with DLA, reflecting the ongoing federal medical procurement needs for brand-name medications supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania and registered in SAM.gov, has demonstrated capability to meet federal procurement requirements through its extensive portfolio of medical product deliveries across multiple therapeutic domains, positioning it as a critical vendor for federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/14/25 |